Citadel Advisors’s CapForce IBD Breakout Opportunities ETF BOUT Stock Holding History
Bought
Maintained
Sold
Other funds holding BOUT
CWM
CMMS
MMCM
HCM
SS
DRP
Citadel Advisors's BOUT Position: Q1 2026 in Review
Citadel Advisors increased its CapForce IBD Breakout Opportunities ETF (BOUT) stake by 14% in Q1 2026, buying an estimated $97.9K and bringing the position to 20,649 shares worth $811K. The position accounts for ﹤0.01% of the portfolio, ranked #8150.
Citadel Advisors first reported a position in BOUT in Q4 2018 and has held it in 18 quarters since. The position peaked at $1.41M in Q4 2024. 14 funds tracked by Wall St. Rank hold BOUT as of Q1 2026.
- Citadel Advisors held 20,649 shares of CapForce IBD Breakout Opportunities ETF worth $811K as of Q1 2026.
- Citadel Advisors bought 2,493 CapForce IBD Breakout Opportunities ETF shares in Q1 2026, an estimated $97.9K.
- CapForce IBD Breakout Opportunities ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #8150 holding.
- Citadel Advisors first reported a position in CapForce IBD Breakout Opportunities ETF in Q4 2018 and has held it in 18 quarters since.
- Citadel Advisors's CapForce IBD Breakout Opportunities ETF position peaked at $1.41M in Q4 2024.
- 14 funds tracked by Wall St. Rank held CapForce IBD Breakout Opportunities ETF as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.